Industry and News Fibromyalgia Treatments Market | Page 2

are allied with other diseases as well, which in turn lowers the diagnosis rate of patients suffering
from fibromyalgia, thus hampering the growth of fibromyalgia treatments Industry.
Segmentation based on type, the fibromyalgia treatments market includes antidepressants,
anticonvulsants, muscle relaxants, analgesics, pain relievers, anti-seizure drugs and therapy.
Segmentation based on application, the fibromyalgia treatments industry includes research centers,
hospitals and clinics and laboratories. Segmentation based on distribution channels, the
fibromyalgia treatments market includes drug stores, hospitals pharmacies, retail pharmacies and
online pharmacies.
Geographically, fibromyalgia treatments industry spans North America, South America, Europe,
Asia-Pacifica, Middle-East and Africa. North America enjoys a significant position owing to presence
of multinational players, rise in research & development investments coupled with rise in healthcare
expenditure. APAC market is also anticipated to grow at a higher CAGR in the forthcoming period
due to rise in geriatric population and drug availability of fibromyalgia.
The key players in the fibromyalgia treatments industry include Leiner Health Products, LNK
International, A&S Pharmaceutical Corporation, Bayer Healthcare, Sanofi, Endo International,
Johnson & Johnson, Purdue Pharma, Teva Pharmaceutical Industries Ltd, Eli Lilly and Company,
Merck and Pfizer Inc.
Get PDF with Technological Trends @ https://www.millioninsights.com/industry-
reports/fibromyalgia-treatments-market/request-sample
Market Segment:
This report studies the global Fibromyalgia Treatments market, analyzes and researches the
Fibromyalgia Treatments development status and forecast in United States, EU, Japan, China,
India and Southeast Asia. This report focuses on the top players in global market, like
• A&S Pharmaceutical Corp
• Leiner Health Products
• LNK International
• Pharmaceutical Formulations